首页> 外文会议>Chinese international peptide symposium >Synthesis, Evaluation and Molecular Modeling Study of L-2-amino-7/8-Bromoalkanoic Acid Derivatives as Histone Deacetylase Inhibitors
【24h】

Synthesis, Evaluation and Molecular Modeling Study of L-2-amino-7/8-Bromoalkanoic Acid Derivatives as Histone Deacetylase Inhibitors

机译:L-2-氨基-7 / 8-溴烷酸衍生物作为组蛋白脱乙酰酶抑制剂的合成,评价和分子建模研究

获取原文

摘要

@@ Modulation of the acetylation state of lysine residues in the N-terminal of core histones plays a pivotal role in the regulation of gene expression[1,2]. Acetylation and deacetylation of histones are controlled by two corresponding enzymes, histone acetyltransferases (HATs) and histone deacetylases (HDACs)'31. In general, HDACs activity relates to transcriptional repression, and abnormal increase in HDACs activity has been associated with the development of some human cancers[4]. Studies indicated that inhibiting HDACs in tumor cells can induce growth arrest, cell proliferation and apoptosis. Therefore HDAC inhibitors (HDACIs) have become a promising class of anticancer agents[5]. Some natural and synthetic compounds have been reported as HDACIs. Almost all HDACIs are comprised of three parts: metal binding, linker and surface recognition domains[6].
机译:@@核心组末端赖氨酸残基的乙酰化状态在基因表达的调节中起枢转作用[1,2]。组蛋白的乙酰化和脱乙酰化由两种相应的酶,组蛋白乙酰转移酶(帽子)和组蛋白脱乙酰酶(HDACS)'31控制。通常,HDACs活性涉及转录抑制,HDACs活性的异常增加与一些人类癌症的发育有关[4]。研究表明,抑制肿瘤细胞中的HDAC可以诱导生长阻滞,细胞增殖和凋亡。因此,HDAC抑制剂(HDACIS)已成为一类有前途的抗癌剂[5]。一些天然和合成的化合物已被报告为HDACIS。几乎所有HDACIS都包括三个部分:金属结合,接头和表面识别结构域[6]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号